AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

PVEK Corneal Implant For Treatment of Corneal Edema

RecruitingPhase 1Ages 18 Years - anyAllPrecise Bio
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn if PVEK, a corneal implant , is safe and well tolerated for people with corneal swelling caused by Fuchs' endothelial dystrophy or pseudophakic bullous keratopathy who need endothelial keratoplasty. The main questions it aims to answer are: What side effects may happen after the PVEK implant? How many participants can complete the first 6 months after surgery without needing another treatment because the implant did not help enough or was not tolerable? This is a Phase 1 (first-in-human) study with one study group, meaning all participants receive the PVEK implant (there is no placebo or comparison group). About 15 participants will take part and will be followed for up to 12 months after surgery. Participants will: Complete screening tests (including eye exams and routine health checks) Have the PVEK implantation surgery Use prescribed

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: age 18/50 years or older Corneal edema requiring endothelial keratoplasty due to Fuchs' endothelial dystrophy and/or pseudophakic bullous keratopathy Pseudophakic study eye Best corrected visual acuity (BCVA) in the study eye between 6/379 (1.8 logMAR) and 6/12 (0.3 logMAR) Central corneal thickness greater than 0.6 mm by OCT Exclusion Criteria: Phakic study eye Study eye is a "single sight eye" (per protocol definition) / fellow eye does not meet protocol vision requirement Malpositioned intraocular lens (dislocation/subluxation) in the study eye Prior ocular procedure in the study eye other than uncomplicated cataract surgery with a stable, centered posterior chamber IOL Axial length below 21 mm or above 26 mm Other significant corneal disease (beyond mild dry eye) or prior keratoplasty in the study eye, or visually significant corneal scarring/opacities not expected to improve with treatment Active ocular or eyelid infection/inflammation; active/prior herpetic ocular infection; uveitis Glaucoma / history or suspicion of elevated IOP, or screening IOP above 23 mmHg (either eye) Synechiae; abnormal anterior segment (e.g., aphakia, aniridia) Corneal endothelial cell density above 1000 cells/mmยฒ at screening (or not reliably measurable) Uncontrolled systemic conditions
๐Ÿ’Š

What it tests

  • Precise Vision Endothelial Keratoplasty (PVEK) Implant
๐Ÿ“

Where

3 sites
Ophthalmological Center After S.V.Malayan
Yerevan, Armenia
Sharei Zedek Medical Center
Jerusalem, Israel
Rambam Medical Center
Haifa, Israel
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy